← All trials
NCT02070705
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2014
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Feb 25, 2014
- Last posted
- Aug 18, 2022
- Enrollment
- 70
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- OHSU Knight Cancer InstituteLead sponsor
- National Cancer Institute (NCI)Collaborator
- National Institutes of Health (NIH)Collaborator
- OHSU Knight Cancer InstituteOverall official - principal investigator
- OHSU Knight Cancer InstituteReponsible party - principal investigator
- Oregon Health and Science UniversityCollaborator
- OHSU Knight Cancer InstituteOfficial
- OHSU Knight Cancer InstituteSponsor investigator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.